CCL5 and metabolic dysfunction-associated steatotic liver disease: Another mechanism of NAFLD-associated HCC is PNPLA3 polymorphisms, which are associated with general NAFLD progression, by enhancing inflammatory signals, including in the IL-6/STAT3 and CCL5 pathways [11].